Keith Lamont Cummings, CFO: Pliant Therapeutics PLRX Sell · Filed 23/07/19

Trade details

Type: Insider sale
Amount: $356,075.71
Shares · price: 19,771 sh · $18.01 a share
Held after: 203,999 sh
Stock: Pliant Therapeutics PLRX
Person: Keith Lamont CummingsCFO
Trade date: 23/07/17
Filed: 23/07/19
Days to filing: 2 days

Sold 8.8% of holdings

Share of holding sold: 8.8%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/17~23/08/16

Keith Lamont Cummings's recent trades

Keith Lamont CummingsCFO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$30.7K
24,002 sh
$30.7K
Filed 01/22
Traded 01/20
Keith Lamont CummingsCFO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$225.7K
20,148 sh
$225.7K
Filed 25/01/22
Traded 25/01/17
Keith Lamont CummingsCFO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$126.1K
10,911 sh
$126.1K
Filed 24/07/12
Traded 24/07/10
Keith Lamont CummingsCFO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$168.5K
9,781 sh
$168.5K
Filed 24/01/19
Traded 24/01/17
Keith Lamont CummingsCFO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$264.1K
9,960 sh
$264.1K
Filed 23/04/03
Traded 23/03/30

Keith Lamont Cummings, CFO — sold $356.1K of Pliant Therapeutics PLRX · 8.8% of holdings · 10b5-1 plan | Whalegun